Pharmacological management of overactive bladder syndrome

A. Bardsley

    Research output: Contribution to journalArticle

    3 Downloads (Pure)

    Abstract

    Overactive bladder (OAB) is a syndrome which affects around 12% of men and women, with incidence increasing with age around 70-80% of people are affected by the age of 80 (1). Patients’ with OAB present with symptoms of urgency, increased daytime frequency and nocturia (2). Around 33% of people with OAB will exhibit urinary incontinence, which affects women more than men. OAB has a significant negative effect on patient’s quality of life and can lead to social isolation and depression (3 and 1). Overactive bladder syndrome with urge incontinence is associated with early institutionalisation, financial cost and increased morbidity and mortality (4)
    Original languageEnglish
    Pages (from-to)19-21
    JournalIndependent Nurse
    Volume2013
    Issue number19
    DOIs
    Publication statusPublished - Jan 2014

    Fingerprint

    Overactive Urinary Bladder
    Pharmacology
    Nocturia
    Urge Urinary Incontinence
    Institutionalization
    Social Isolation
    Urinary Incontinence
    Quality of Life
    Depression
    Morbidity
    Costs and Cost Analysis
    Mortality
    Incidence

    Cite this

    Pharmacological management of overactive bladder syndrome. / Bardsley, A.

    In: Independent Nurse, Vol. 2013, No. 19, 01.2014, p. 19-21.

    Research output: Contribution to journalArticle

    Bardsley, A. / Pharmacological management of overactive bladder syndrome. In: Independent Nurse. 2014 ; Vol. 2013, No. 19. pp. 19-21.
    @article{553c95ac8a0f4c4aafca6d98450d98cf,
    title = "Pharmacological management of overactive bladder syndrome",
    abstract = "Overactive bladder (OAB) is a syndrome which affects around 12{\%} of men and women, with incidence increasing with age around 70-80{\%} of people are affected by the age of 80 (1). Patients’ with OAB present with symptoms of urgency, increased daytime frequency and nocturia (2). Around 33{\%} of people with OAB will exhibit urinary incontinence, which affects women more than men. OAB has a significant negative effect on patient’s quality of life and can lead to social isolation and depression (3 and 1). Overactive bladder syndrome with urge incontinence is associated with early institutionalisation, financial cost and increased morbidity and mortality (4)",
    author = "A. Bardsley",
    year = "2014",
    month = "1",
    doi = "10.12968/indn.2013.19.19",
    language = "English",
    volume = "2013",
    pages = "19--21",
    journal = "Independent Nurse",
    issn = "1747-9800",
    publisher = "MA Healthcare",
    number = "19",

    }

    TY - JOUR

    T1 - Pharmacological management of overactive bladder syndrome

    AU - Bardsley, A.

    PY - 2014/1

    Y1 - 2014/1

    N2 - Overactive bladder (OAB) is a syndrome which affects around 12% of men and women, with incidence increasing with age around 70-80% of people are affected by the age of 80 (1). Patients’ with OAB present with symptoms of urgency, increased daytime frequency and nocturia (2). Around 33% of people with OAB will exhibit urinary incontinence, which affects women more than men. OAB has a significant negative effect on patient’s quality of life and can lead to social isolation and depression (3 and 1). Overactive bladder syndrome with urge incontinence is associated with early institutionalisation, financial cost and increased morbidity and mortality (4)

    AB - Overactive bladder (OAB) is a syndrome which affects around 12% of men and women, with incidence increasing with age around 70-80% of people are affected by the age of 80 (1). Patients’ with OAB present with symptoms of urgency, increased daytime frequency and nocturia (2). Around 33% of people with OAB will exhibit urinary incontinence, which affects women more than men. OAB has a significant negative effect on patient’s quality of life and can lead to social isolation and depression (3 and 1). Overactive bladder syndrome with urge incontinence is associated with early institutionalisation, financial cost and increased morbidity and mortality (4)

    U2 - 10.12968/indn.2013.19.19

    DO - 10.12968/indn.2013.19.19

    M3 - Article

    VL - 2013

    SP - 19

    EP - 21

    JO - Independent Nurse

    JF - Independent Nurse

    SN - 1747-9800

    IS - 19

    ER -